Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert


Search Title by author or title

Clinical outcomes of a new trifocal intraocular lens with enhanced light energy technology

Poster Details

First Author: B.Bostanci TURKEY

Co Author(s):    A. Karatepe Hashas   E. Tasindi                 

Abstract Details


To evaluate the refractive, visual and contrast sensitivity outcomes with subjective results after implantation of a new trifocal intraocular lens (IOL).


Okan University Hospital, Ophthalmology Department, �Ä�°stanbul, Turkey


The study included 44 eyes of 22 patients, which received Acrysof IQ Panoptix (�.17 diopter (D) /�.25 D IOL, Alcon Surgical, Inc.) IOL after cataract surgery. Refraction; binocular and monocular corrected and uncorrected distance, intermediate (66 cm) and near (33 cm) visual acuities (VA) and contrast sensitivity was measured at the 3 months postoperative visit. Level of capsule opacification and stabilization of the IOL was noted and photic phenomena (glare, halo, dysphotopsia) were questioned additionally.


Mean age of the patients was 63.4�Â�±7.1. At the 3rd month visit, mean spherical equivalent was 0.31�Â�±0.20D. Mean uncorrected and corrected monocular distance VA was 0.05�Â�±0.10LogMAR and 0.00�Â�±0.08LogMAR respectively. Mean binocular uncorrected VA was �â�ˆ�’0.04�Â�±0.09LogMAR. Binocular near VA was Jaeger(J)2 or 1 in 95% of the patients whereas, 90% read J2 or 1 in the intermediate distance. Mean contrast sensitivity was between normal limits in mezopic and photopic conditions. Posterior capsule opacification necessitating neodymium:YAG lazer capsulotomy or lens decentration was not observed. Two cases with 1 D or more postoperative cylindrical error reported glare problems.


The new trifocal IOL design provided stable refractive correction and desirable visual restoration for distant, intermediate and near vision with satisfactory visual quality.

Financial Disclosure:


Back to Poster listing